New Haven, CTNCT07218146Now EnrollingIRB Ready

Small-cell Lung Cancer Clinical Trial in New Haven, CT

Access cutting-edge small-cell lung cancer treatment through this clinical trial at a research site in New Haven. Study-provided care at no cost to qualified participants.

Sponsored by Zai Lab (Shanghai) Co., Ltd.

Quick Self-Assessment

See if you qualify for this New Haven location

Preparing your pre-screening questions…

Expert Care in New Haven

Access small-cell lung cancer specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related small-cell lung cancer treatment provided free

Apply for This New Haven Location

Check if you qualify for this small-cell lung cancer clinical trial in New Haven, CT

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to New Haven

    Convenient for CT residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit New Haven site if eligible
  4. 4Begin participation

About This Small-cell Lung Cancer Study in New Haven

The purpose of this study is to evaluate the efficacy and safety of ZL-1310 compared to Investigator's Choice Therapy in participants with relapsed Small Cell Lung Cancer.

Sponsor: Zai Lab (Shanghai) Co., Ltd.

Who Can Participate

Inclusion Criteria

Age \>/= 18 years, or considered an adult by local regulations, at the time of consent
Signed informed consent
Histologically or cytologically confirmed SCLC. Received 1L platinum-based systemic therapy and had documented disease progression during or after the most recent systemic therapy. Or received 2L tarlatamab is allowed.
Measurable disease according to RECIST v1.1 as assessed by the investigator.
Participants with a history of treated and stable or untreated and asymptomatic CNS metastases based on criteria per protocol.
Adequate organ and marrow function
Eastern Cooperative Group (ECOG) performance status of 0 or 1
Life expectancy of at least 3 months
Participants must be willing to undergo a tumor biopsy or provide archived tumor tissue sample at Screening
Participants must be willing and able to comply with protocol for the duration of the study

Exclusion Criteria

Received more than one line of systemic therapy for Extensive-Stage SCLC.
Received any prior ADC with topoisomerase 1 inhibitor payload
Participants with another known malignancy with exceptions defined in the protocol.
History or suspected ILD/pneumonitis based on criteria per protocol
Clinically severe pulmonary compromise resulting from intercurrent pulmonary illnesses.
Receipt of anti-cancer treatment known to treat cancers within 3 weeks before the first dose of study treatment.
Prior radiotherapy before study treatment based on criteria per protocol
Unresolved toxicity of Grade \>/= 2 from previous anti-cancer treatment, except for alopecia and skin pigmentation.
Known infection or active infection defined in the protocol.
Clinically significant active cardiovascular disease or history of arterial thromboembolic event within 6 months prior to the first dose of study treatment based on criteria per protocol.

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in New Haven?

Yes, this clinical trial (NCT07218146) has an active research site in New Haven, CT that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Small-cell Lung Cancer Treatment Options in New Haven, CT

If you're searching for small-cell lung cancer treatment options in New Haven, CT, this clinical trial (NCT07218146) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our New Haven research site is actively enrolling participants for this clinical trial. You'll receive care from experienced small-cell lung cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all small-cell lung cancer clinical trials near you to find additional studies recruiting in your area.

More Lung Cancer Trials in New Haven, CT

See all lung cancer clinical trials recruiting in New Haven — not just this study.

Browse Lung Cancer Trials in New Haven →

Browse More Trials by Condition

Lung Cancer TrialsLeukemia TrialsSpinal Muscular Atrophy TrialsAll Conditions →

Ready to Join in New Haven?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · New Haven, CT